Immunosuppressant
Showing 1 - 25 of 635
Medication Adherence, Liver Transplantation, Kidney Transplantation Trial in Miami, Baltimore, Charlottesville (mHealth
Recruiting
- Medication Adherence
- +2 more
- mHealth intervention
- standard of care
-
Baltimore, Maryland
- +1 more
Sep 22, 2022
Pirfenidone, Connective Tissue Diseases, Interstitial Lung Disease Trial in Jinan (Pirfenidone, glucocorticoid and
Recruiting
- Pirfenidone
- +2 more
- Pirfenidone
- glucocorticoid and immunosuppressant
-
Jinan, Shandong, ChinaQilu Hospital
Aug 16, 2022
Inebilizumab in Acute Neuromyelitis Optica Spectrum Disorders
Not yet recruiting
- Neuromyelitis Optica Spectrum Disorder
- Inebilizumab
- oral immunosuppressant
- (no location specified)
Jun 5, 2023
Complications in Patients Received Liver Transplantation: A
Active, not recruiting
- Liver Transplant, Liver Cancer, Immunosuppressant
-
Taichung, TaiwanChina Medical University Hospital
Oct 17, 2022
Medication Adherence, Kidney Transplant Trial in Baltimore (mHealth Intervention)
Completed
- Medication Adherence
- Kidney Transplant
- mHealth Intervention
-
Baltimore, MarylandJohns Hopkins Hospital
Oct 12, 2021
Medication Adherence, Liver Transplant Trial in Baltimore (mHealth Intervention)
Withdrawn
- Medication Adherence
- Liver Transplant
- mHealth Intervention
-
Baltimore, MarylandJohns Hopkins Hospital
Sep 17, 2021
Medication Adherence, Transplant; Kidney Trial in Baltimore (mHealth Intervention)
Withdrawn
- Medication Adherence
- Transplant; Kidney
- mHealth Intervention
-
Baltimore, MarylandJohns Hopkins Hospital
Sep 17, 2021
Medication Adherence, Liver Transplantation Trial in Baltimore (mHealth Intervention)
Withdrawn
- Medication Adherence
- Liver Transplantation
- mHealth Intervention
-
Baltimore, MarylandJohns Hopkins Hospital
Sep 17, 2021
Liver Transplant; Complications, Renal Insufficiency, Immunosuppressant Adverse Reaction Trial in Edmonton (Envarsus Oral
Suspended
- Liver Transplant; Complications
- +4 more
- Envarsus Oral Product
- Prograf (SOC)
-
Edmonton, Alberta, CanadaUniverity of Alberta
Jul 7, 2022
Long-term Benefit of MPA in Liver Transplantation
Recruiting
- Liver Transplant Rejection
- Immunosuppressant Adverse Reaction
- enteric-coated mycophenolate (MPAs)
- None MPA
-
Guangzhou, Guangdong, ChinaThird Affiliated Hospital, Sun Yat-Sen University
Jan 28, 2023
Autoimmune Diseases Trial in Beijing (Drug free, IS monotherapy and GC combined with IS)
Recruiting
- Autoimmune Diseases
- Drug free, IS monotherapy and GC combined with IS
-
Beijing, Beijing, ChinaBeijing Friendship Hospital
Jan 21, 2022
Acute Rejection of Liver Transplant, Effects of Immunosuppressant Therapy Trial in Chicago (Sirolimus)
Completed
- Acute Rejection of Liver Transplant
- Effects of Immunosuppressant Therapy
-
Chicago, IllinoisNorthwestern University
Mar 4, 2021
End-Stage Renal Disease Trial in Vancouver (Conversion to Advagraf, conversion of non-immunosuppressant drugs to once daily,
Active, not recruiting
- End-Stage Renal Disease
- Conversion to Advagraf
- +2 more
-
Vancouver, British Columbia, Canada
- +2 more
Oct 5, 2021
Kidney Transplant Rejection, Medication Adherence Trial in Aurora (Medication Event Monitoring System (MEMS), Once-Daily
Terminated
- Kidney Transplant Rejection
- Medication Adherence
- Medication Event Monitoring System (MEMS)
- Once-Daily Tacrolimus extended release
-
Aurora, ColoradoChildren's Hospital Colorado
Nov 30, 2020
COVID-19 Infection in Chronic Plaque Psoriasis on
Unknown status
- Coronavirus Infection
- Nasopharyngeal swab
- (no location specified)
Mar 26, 2020
Medication Adherence, Kidney Transplantation Trial in London (Pharmacist led medication adherence interventions)
Completed
- Medication Adherence
- Kidney Transplantation
- Pharmacist led medication adherence interventions
-
London, United KingdomImperial College Renal and Transplant Centre
Jul 29, 2020
Disorder Related to Renal Transplantation, Effects of Immunosuppressant Therapy Trial in Worldwide (Tacrolimus (for Group B),
Completed
- Disorder Related to Renal Transplantation
- Effects of Immunosuppressant Therapy
- Tacrolimus (for Group B)
- +5 more
-
Prague, Prague 4, Czechia
- +7 more
Jan 28, 2021
Type 1 Diabetes Trial in San Francisco (Belatacept and Raptiva)
Completed
- Type 1 Diabetes
- Belatacept and Raptiva
-
San Francisco, CaliforniaUniversity of California, San Francisco
Apr 30, 2020
Kidney Transplant Patients
Completed
- Adherence, Medication
- Transplantation, Kidney
- Focus group
-
London, United KingdomImperial College Renal and Transplant Centre
Jun 4, 2019
Crohn Disease Trial in Leuven (ABX464, Placebo)
Unknown status
- Crohn Disease
- ABX464
- Placebo
-
Leuven, BelgiumUniversity Hospitals Leuven - campus Gasthuisberg
Dec 19, 2019
Immune Mediated Anemia, Immune Mediated Thrombocytopenia, Chronic GVHD Trial run by the National Heart, Lung, and Blood
Not yet recruiting
- Immune Mediated Anemia
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 17, 2022
Undifferentiated Connective Tissue Disease, Recurrent Pregnancy Loss Trial in Shanghai (Prednisone, Hydroxychloroquine, Aspirin)
Unknown status
- Undifferentiated Connective Tissue Disease
- Recurrent Pregnancy Loss
- Prednisone
- +3 more
-
Shanghai, Shanghai, ChinaRenji Hospital
Aug 8, 2019
Transplant;Failure,Kidney, Transplant; Failure, Liver, Adherence, Medication Trial (mHealth Messaging Intervention Group)
Not yet recruiting
- Transplant;Failure,Kidney
- +4 more
- mHealth Messaging Intervention Group
- (no location specified)
Nov 4, 2022
Psychological Stress, Hypertension, Renal Trial in Augusta (mycophenolate mofetil (MMF), Placebo)
Unknown status
- Psychological Stress
- Hypertension, Renal
- mycophenolate mofetil (MMF)
- Placebo
-
Augusta, GeorgiaAugusta University
Jun 19, 2019